Medical Device Innovation Consortium - MDIC

07/27/2023

📢 Just announced!

Micky Tripathi, National Coordinator for Health Information Technology at the U.S. Department of Health and Human Services, will be speaking at the MDIC 2023 Annual Public Forum!

Dr. Tripathy will offer insights drawn from his two decades of expertise in the health IT landscape to discuss the imperative of health information interoperability, the current landscape with regard to information blocking policy and data sharing, and the future of a health care system driven by data-rich medical devices.

Register Now!
https://whova.com/portal/registration/mapf_202306/

07/26/2023

📣 Just announced!

HHS Deputy Secretary and health policy veteran Andrea Palm will participate in the MDIC 2023 Annual Public Forum!

In this highly anticipated session, HHS Deputy Secretary and health policy veteran Andrea Palm will share her leadership perspective on preventing cyberattacks in the health care system, raising the level of cybersecurity expertise and preparedness, and ensuring resilience among hospitals and other health care organizations.

Register Now! https://whova.com/portal/registration/mapf_202306/

07/20/2023

We are thrilled to announce that registration for MDIC's 2023 Annual Public Forum, scheduled for September 19-20 in Washington, DC, is now open! The theme is Insight. Innovation. Impact. This once-a-year event will bring together industry experts, patient advocates, regulators, and other community innovators to transform the future of medical technology and diagnostics. Topics to be discussed: health equity, cybersecurity, real-world evidence, and more.

Register here: https://whova.com/portal/registration/mapf_202306/

Sign up for email updates to be among the first to hear news on MDIC’s flagship annual event: https://share.hsforms.com/1P6L0HlrQRZy0TO62Ww8CKwc7spp

07/06/2023

Attention medical device manufacturers! If you couldn't make it to our AMCH Application Process Webinar and Q&A Session on June 26th, we've got you covered!

🎥💻 The webinar is now available on-demand! Discover how you can apply for funding through the Advanced Manufacturing Clearing House (AMCH) program at MDIC and secure up to $300,000 USD for your digital transformation projects.

🚀🔬 Watch the webinar recording featuring our experts Prakash Patwardhan and Steve Zera here: https://mdic.tech/3JMX070

Are you working on an advanced technology project that supports digital transformation? Don’t miss out on the opportunity to apply for funding through the Ad...

06/28/2023

In Case You Missed It ( ): The Article "Early Feasibility Study programme has potential to advance US neurovascular space" discusses MDIC's Early Feasibility Studies program and its role in the advancing neurovascular space.

"At a time when many of Europe’s medical technology markets are effectively going backwards due to complications created by the EU Medical Device Regulation (MDR), corresponding sectors in the USA are receiving an inevitable boost. Alongside the US Food and Drug Administration (FDA), the country’s leading clinicians and industry figures have seized this opportunity—and, thanks to the Early Feasibility Study (EFS) programme, can now potentially play a leading role in advancing novel devices within the neurovascular space."

Visit https://mdic.tech/3qQu5bB to read the full article from NeuroNews!

06/27/2023

The highly anticipated Pathology Innovation Collaborative Community Annual In-Person Meeting ( ) is now underway!

Domain experts from around the world have gathered here to explore cutting-edge advancements and breakthroughs in the field of pathology. 🌍💡

🗓️ Day 1 will feature plenty of engaging talks and thought-provoking discussions. It's an incredible opportunity to connect with peers, share insights, and shape the future of pathology. 🤝🧠

📸🔍 Here are a few glimpses from today's opening sessions to give you a taste of the inspiring atmosphere and captivating discussions happening here at the meeting.

Take a look! 👀✨

06/23/2023

At a time when many of Europe’s medical technology markets are effectively going backwards due to complications created by the EU Medical Device Regulation (MDR), corresponding sectors in the USA are receiving an inevitable boost. Alongside the US Food and Drug Administration (FDA), the country’...

06/20/2023

🔔 Last Chance to Register! 🔔

Don't miss out on the opportunity to join us at the highly anticipated annual meeting "PIcc23: Unlocking the Potential of Digital Pathology and Artificial Intelligence (AI) through Regulatory Science" in the Washington DC metro area on Jun 27-28, 2023, brought to you by the Medical Device Innovation Consortium (MDIC) and the Pathology Innovation Collaborative Community (PIcc).

Why you should attend:

🤝 Network with domain experts who are passionate about advancing regulatory science through engaging in-person working sessions.
🔍 Get the most comprehensive overview of digital pathology and AI from a multi-stakeholder organization.
💡 Share your unique perspective with the entire community.
🚀 Collaborate on large-scale projects to develop practical regulatory science tools and templates.

At , you'll have the opportunity to connect with thought-leaders, regulators, and pioneers in digital pathology to discuss:

💻 Advances in digital pathology and AI applications.
🌟 How these advances create new incentives to implement digital pathology and AI/ML on a broader scale.
📚 The impact of regulatory and legislative developments on digital pathology and AI tools in diagnostics following the end of the COVID-19 pandemic public health emergency.
🔬 And much more!

Register now for this exciting event at: https://mdic.tech/43JzGim

Use the code EARLYPICC to access the earlybird pricing discount!

For further details about the event and sponsorship opportunities, feel free to contact a member of the PIcc team at picc@mdic.org.

Hurry, time is running out! Secure your spot today

Join the conversation:

Hurry, time is running out! Secure your spot today!

06/15/2023

Attention medical device companies! Are you curious about the Advanced Manufacturing Clearing House (AMCH) program? Join our upcoming webinar on June 26th at 1 PM Eastern to learn more. Discover how to submit a successful application, better understand the submission criteria, eligibility requirements, and the unparalleled value of being part of the Medical Device Innovation Consortium's AMCH program. Register now for this exclusive opportunity:

Are you working on an advanced technology project that supports digital transformation? Don’t miss out on the opportunity to apply for funding through the Advanced Manufacturing Clearing House (AMCH) program at MDIC.

05/26/2023

Looking to receive updates from specific MDIC programs? Sign-up to join program-specific mailing lists to stay up to date on MDIC's work in your chosen areas of interest.

Visit https://mdic.tech/3O11728 to sign up.

 Sign-up to join program-specific mailing lists to stay up to date on MDIC's work in your chosen areas of interest. Click the button that coordinates to your program area of interest to sign up for that program's mailings.

05/23/2023

EFS Express is a quarterly newsletter that provides updates on MDIC's early feasibility studies (EFS) projects, shares educational resources, and highlights EFS success stories and best practices.

Visit https://mdic.tech/44U3FVO to sign up and receive updates on all things Early Feasibility Studies!

05/22/2023

In vitro testing of hemolysis and thrombosis is essential for the development of various blood-contacting devices. Computational fluid dynamics (CFD) has also proven to be a useful, complementary tool for understanding mechanical sources of damage, i.e. shear stress, exposure time, and recirculation, but it lacks clear regulatory impact. The goal of the MDIC Blood Damage Modeling Working Group is to generate credible physical test data that can then be used to support the development and validation of computational models of blood damage. These models will help medical device developers understand and optimize their devices to minimize the effects of blood damage during the product development stage and, potentially, assist in assessing safety in a regulatory submission. The group is comprised of industry members developing blood-contacting devices and scientists from the US FDA, Center for Devices and Radiological Health (CDRH), Office of Science and Engineering Labs (OSEL).

MDIC and MDIC's Computational Modeling and Simulation Steering committee welcome subject matter experts who are excited to assist with the development and evaluation of in vitro or in silico methods for estimating mechanical blood damage.

Contact cms@mdic.org for more information.